Review



hcc1937 breast cancer cell lines  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 97
      Buy from Supplier

    Structured Review

    ATCC hcc1937 breast cancer cell lines
    A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, <t>HCC1937,</t> and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.
    Hcc1937 Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1232 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1937 breast cancer cell lines/product/ATCC
    Average 97 stars, based on 1232 article reviews
    hcc1937 breast cancer cell lines - by Bioz Stars, 2026-06
    97/100 stars

    Images

    1) Product Images from "S6K1 and S6K2 regulate homologous recombination DNA repair through control of BRCA1 protein stability"

    Article Title: S6K1 and S6K2 regulate homologous recombination DNA repair through control of BRCA1 protein stability

    Journal: bioRxiv

    doi: 10.64898/2026.04.28.721439

    A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, HCC1937, and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.
    Figure Legend Snippet: A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, HCC1937, and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.

    Techniques Used:



    Similar Products

    hcc1937 breast cancer cell lines  (ATCC)
    97
    ATCC hcc1937 breast cancer cell lines
    A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, <t>HCC1937,</t> and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.
    Hcc1937 Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1937 breast cancer cell lines/product/ATCC
    Average 97 stars, based on 1 article reviews
    hcc1937 breast cancer cell lines - by Bioz Stars, 2026-06
    97/100 stars
    		  Buy from Supplier
    cell lines construction human triple negative breast cancer cell lines  (ATCC)
    97
    ATCC cell lines construction human triple negative breast cancer cell lines
    A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, <t>HCC1937,</t> and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.
    Cell Lines Construction Human Triple Negative Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines construction human triple negative breast cancer cell lines/product/ATCC
    Average 97 stars, based on 1 article reviews
    cell lines construction human triple negative breast cancer cell lines - by Bioz Stars, 2026-06
    97/100 stars
    		  Buy from Supplier
    negative breast cancer cell lines hcc1937  (ATCC)
    97
    ATCC negative breast cancer cell lines hcc1937
    A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, <t>HCC1937,</t> and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.
    Negative Breast Cancer Cell Lines Hcc1937, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/negative breast cancer cell lines hcc1937/product/ATCC
    Average 97 stars, based on 1 article reviews
    negative breast cancer cell lines hcc1937 - by Bioz Stars, 2026-06
    97/100 stars
    		  Buy from Supplier
    human triple negative breast cancer cell lines hcc1937  (ATCC)
    97
    ATCC human triple negative breast cancer cell lines hcc1937
    A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, <t>HCC1937,</t> and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.
    Human Triple Negative Breast Cancer Cell Lines Hcc1937, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human triple negative breast cancer cell lines hcc1937/product/ATCC
    Average 97 stars, based on 1 article reviews
    human triple negative breast cancer cell lines hcc1937 - by Bioz Stars, 2026-06
    97/100 stars
    		  Buy from Supplier
    hcc1937 breast cancer cell line  (ATCC)
    97
    ATCC hcc1937 breast cancer cell line
    Percent of cell proliferation of <t>HCC1937</t> ​cell line exposed to (a) PCX (5, 10, 20, 50, or 100 ​nM), and (b) CLAV (0.1, 0.5, 1, 10, 100, or 250 ​μM). Each bar represents the mean ​± ​standard error of two independent experiments. Asterisks denote significant difference (∗∗p ​< ​0.01, and ∗∗∗∗p ​< ​0.0001 vs VEH) according to one-way ANOVA followed by post-hoc Tukey's test.
    Hcc1937 Breast Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1937 breast cancer cell line/product/ATCC
    Average 97 stars, based on 1 article reviews
    hcc1937 breast cancer cell line - by Bioz Stars, 2026-06
    97/100 stars
    		  Buy from Supplier
    breast cancer cell lines  (ATCC)
    97
    ATCC breast cancer cell lines
    Percent of cell proliferation of <t>HCC1937</t> ​cell line exposed to (a) PCX (5, 10, 20, 50, or 100 ​nM), and (b) CLAV (0.1, 0.5, 1, 10, 100, or 250 ​μM). Each bar represents the mean ​± ​standard error of two independent experiments. Asterisks denote significant difference (∗∗p ​< ​0.01, and ∗∗∗∗p ​< ​0.0001 vs VEH) according to one-way ANOVA followed by post-hoc Tukey's test.
    Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/breast cancer cell lines/product/ATCC
    Average 97 stars, based on 1 article reviews
    breast cancer cell lines - by Bioz Stars, 2026-06
    97/100 stars
    		  Buy from Supplier
    human breast cancer cell lines  (ATCC)
    97
    ATCC human breast cancer cell lines
    Percent of cell proliferation of <t>HCC1937</t> ​cell line exposed to (a) PCX (5, 10, 20, 50, or 100 ​nM), and (b) CLAV (0.1, 0.5, 1, 10, 100, or 250 ​μM). Each bar represents the mean ​± ​standard error of two independent experiments. Asterisks denote significant difference (∗∗p ​< ​0.01, and ∗∗∗∗p ​< ​0.0001 vs VEH) according to one-way ANOVA followed by post-hoc Tukey's test.
    Human Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human breast cancer cell lines/product/ATCC
    Average 97 stars, based on 1 article reviews
    human breast cancer cell lines - by Bioz Stars, 2026-06
    97/100 stars
    		  Buy from Supplier
    breast cancer cell lines hcc1937  (European Collection of Authenticated Cell Cultures)
    90
    European Collection of Authenticated Cell Cultures breast cancer cell lines hcc1937
    Percent of cell proliferation of <t>HCC1937</t> ​cell line exposed to (a) PCX (5, 10, 20, 50, or 100 ​nM), and (b) CLAV (0.1, 0.5, 1, 10, 100, or 250 ​μM). Each bar represents the mean ​± ​standard error of two independent experiments. Asterisks denote significant difference (∗∗p ​< ​0.01, and ∗∗∗∗p ​< ​0.0001 vs VEH) according to one-way ANOVA followed by post-hoc Tukey's test.
    Breast Cancer Cell Lines Hcc1937, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/breast cancer cell lines hcc1937/product/European Collection of Authenticated Cell Cultures
    Average 90 stars, based on 1 article reviews
    breast cancer cell lines hcc1937 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, HCC1937, and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.

    Journal: bioRxiv

    Article Title: S6K1 and S6K2 regulate homologous recombination DNA repair through control of BRCA1 protein stability

    doi: 10.64898/2026.04.28.721439

    Figure Lengend Snippet: A) Scheme of treatment used in the experiment. B, C, D) Treatment of MDA-MB-231, HCC1937, and MCF7 cells with Olaparib and PF4708671 (PF47) alone or with PF47 pretreatment followed by olaparib treatment (PF + Ola). The PF47 dose used for all cells was 20 µM for 24 hours. The olaparib dose used for MDA-MB-231 and HCC1937 was 80 µM, and for MCF7 it was 160 µM for 6 days. Two-way ANOVA with Dunnett’s post-hoc test was used for statistical analysis and results are presented as mean ± SD of 3 biological replicates. **=p<0.01; ***=p<00.1; ****=p<000.1.

    Article Snippet: MCF7, MDA-MB-231 and HCC1937 breast cancer cell lines were originally obtained from the ATCC and were a gift from Prof. Sandra Martha Gomes Dias.

    Techniques:

    Percent of cell proliferation of HCC1937 ​cell line exposed to (a) PCX (5, 10, 20, 50, or 100 ​nM), and (b) CLAV (0.1, 0.5, 1, 10, 100, or 250 ​μM). Each bar represents the mean ​± ​standard error of two independent experiments. Asterisks denote significant difference (∗∗p ​< ​0.01, and ∗∗∗∗p ​< ​0.0001 vs VEH) according to one-way ANOVA followed by post-hoc Tukey's test.

    Journal: Neurotherapeutics

    Article Title: Clavulanic acid prevents paclitaxel-induced neuropathic pain through a systemic and central anti-inflammatory effect in mice

    doi: 10.1016/j.neurot.2024.e00522

    Figure Lengend Snippet: Percent of cell proliferation of HCC1937 ​cell line exposed to (a) PCX (5, 10, 20, 50, or 100 ​nM), and (b) CLAV (0.1, 0.5, 1, 10, 100, or 250 ​μM). Each bar represents the mean ​± ​standard error of two independent experiments. Asterisks denote significant difference (∗∗p ​< ​0.01, and ∗∗∗∗p ​< ​0.0001 vs VEH) according to one-way ANOVA followed by post-hoc Tukey's test.

    Article Snippet: The HCC1937 breast cancer cell line was obtained from the ATCC cell bank (Manassas, VA, USA).

    Techniques:

    Percent of cell proliferation of HCC1937 ​cell line exposed to CLAV (1, 10, 50, or 100 ​μM) in absence or in the presence of PCX (5 ​nM) for 48 ​h. The effect of PCX (5 ​nM) alone was also showed. Each bar represents the mean ​± ​standard error of three independent experiments. Asterisks denote significant difference (∗∗p ​< ​0.01 vs VEH) according to one-way ANOVA followed by Tukey's post hoc test.

    Journal: Neurotherapeutics

    Article Title: Clavulanic acid prevents paclitaxel-induced neuropathic pain through a systemic and central anti-inflammatory effect in mice

    doi: 10.1016/j.neurot.2024.e00522

    Figure Lengend Snippet: Percent of cell proliferation of HCC1937 ​cell line exposed to CLAV (1, 10, 50, or 100 ​μM) in absence or in the presence of PCX (5 ​nM) for 48 ​h. The effect of PCX (5 ​nM) alone was also showed. Each bar represents the mean ​± ​standard error of three independent experiments. Asterisks denote significant difference (∗∗p ​< ​0.01 vs VEH) according to one-way ANOVA followed by Tukey's post hoc test.

    Article Snippet: The HCC1937 breast cancer cell line was obtained from the ATCC cell bank (Manassas, VA, USA).

    Techniques: